Rare Disease Clinical Trials Market Forecast 2025–2034
Market Scope The Global Rare Disease Clinical Trials Market is valued at US$ 13.5 billion in 2025 and is projected to reach US$ 28.6 billion by 2034, expanding at a CAGR of 8.7% from 2025 to 2034. The market covers the ecosystem involved in developing, managing, and conducting clinical trials for rare and orphan diseases, including genetic, neurological, metabolic, hematologic, and ultra-rare...
0 Comments 0 Shares 58 Views 0 Reviews
Sponsored